![](/img/cover-not-exists.png)
829TiPMulticenter randomized phase II trial of 5-fluorouracil/leucovorin (5-FU/LV) with or without liposomal irinotecan (nal-IRI) in metastatic biliary tract cancer (BTC) as second-line therapy after progression on gemcitabine plus cisplatin (GemCis): NIFTY trial
Yoo, C, Jeong, J H, Kim, K-P, Cheon, J, Kim, I, Kang, M, Ryu, H, Kang, B W, Ryoo, B-YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.155
Date:
October, 2019
File:
PDF, 77 KB
2019